Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review
Medulloblastoma (MB) is the most common malignant tumor of the central nervous system in pediatric patients. Despite the complex anticancer therapy approach, refractory and relapsing forms of the disease remain fatal in most cases and account for approximately 30%. To date, repeated surgery, radiati...
Main Authors: | Yulia V. Dinikina, Olga G. Zheludkova, Margarita B. Belogurova, Dmitry M. Spelnikov, Nikolai N. Osipov, Irina L. Nikitina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2023-12-01
|
Series: | Современная онкология |
Subjects: | |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/viewFile/492325/pdf |
Similar Items
-
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment
by: Rebecca M. Hill, et al.
Published: (2021-12-01) -
Retrospective National “Real Life” Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol
by: Camille Winnicki, et al.
Published: (2023-02-01) -
Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses
by: Konstantin Okonechnikov, et al.
Published: (2023-01-01) -
Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma
by: Liana Nobre, et al.
Published: (2020-06-01) -
Is adult medulloblastoma merely the counterpart of pediatric medulloblastoma?
by: Gabriel Chun-Hei Wong, et al.
Published: (2020-01-01)